TY - JOUR
T1 - Cervical Lymph Node Invasion in Pediatric Salivary Gland Malignancies
T2 - Clinical Overview and Therapeutic Implications
AU - Richard, Celine
AU - Carton, Matthieu
AU - Hazkani, Inbal
AU - Couloigner, Vincent
AU - Sheyn, Anthony
AU - Rastatter, Jeffrey
AU - Haroun, Linda
AU - Helmig, Sara
AU - Houston, Mary Beth
AU - Helfre, Sylvie
AU - Thebault, Eric
AU - Andre, Nicolas
AU - Faure Conter, Cecile
AU - Teissier, Natacha
AU - Fresneau, Brice
AU - Orbach, Daniel
N1 - Publisher Copyright:
© 2025 Wiley Periodicals LLC.
PY - 2025
Y1 - 2025
N2 - Background and Aims: Pediatric salivary gland malignancies (SGM) present challenges in managing cervical nodes. We aimed to characterize lymph node invasion to inform decisions regarding the need of systematic wide lymph node dissection (WLND). Methods: International retrospective study, conducted across seven large French and American pediatric centers, including pediatric patients (0–18 years) diagnosed with SGM from 2000 to 2020. Results: Among the 82 patients (median age 13 years), the parotid gland was frequently affected (60 cases). Histotypes comprised mucoepidermoid (mucoepidermoid carcinoma [MEC], 43 cases), acinic cells (acinic cells carcinoma [AcCC], 22 cases), adenoid cystic (adenoid cystic carcinoma [AdCC], 8 cases), (MASC, 6 cases), and adenocarcinoma (3 cases). Primary treatments were surgery (82 cases) and radiotherapy (20 cases; median dosage 64 gray). Cervical nodes therapy included WLND (≥2 levels, 29 cases), limited nodes resection (LNR; one level, 13 cases), and/or irradiation (4 cases; median 54 gray; range 52.0–63.0). At diagnosis, six patients had cervical node invasion (CNI) managed with LNR (four cases), WLND (two cases), and radiotherapy (three cases). After a median follow-up of 6 years (range 1–22), nine patients had tumor event: local (four cases), cervical relapse/progression (three cases) or combined (two cases). Of the nine with CNI, at diagnosis or relapse, four had MASC. Five-year event-free and overall survival (OS) rates were, respectively, 90.1% and 98.8%. Conclusions: CNI is rare in pediatric SGM but noted in 11% of cases, with higher incidence in MASC. Overall, outcome in SGM is good with a tailored locoregional multidisciplinary approach. Systematic lymph node dissection should be reconsidered. SUMMARY: This international multi-institutional study analyzed the clinical presentation and the cervical pattern of relapse of 82 pediatric patients with newly diagnosed salivary gland malignancies. Overall, nodal invasion was rare at diagnosis and only noted in 7%. In addition, 6% developed nodal relapse during follow-up. Incidence of nodal spread was frequent in mammary analogue secretory carcinoma (MASC). The overall outcome was promising with a tailored locoregional multidisciplinary approach. Systematic lymph node dissection should be reconsidered in pediatric salivary gland tumors.
AB - Background and Aims: Pediatric salivary gland malignancies (SGM) present challenges in managing cervical nodes. We aimed to characterize lymph node invasion to inform decisions regarding the need of systematic wide lymph node dissection (WLND). Methods: International retrospective study, conducted across seven large French and American pediatric centers, including pediatric patients (0–18 years) diagnosed with SGM from 2000 to 2020. Results: Among the 82 patients (median age 13 years), the parotid gland was frequently affected (60 cases). Histotypes comprised mucoepidermoid (mucoepidermoid carcinoma [MEC], 43 cases), acinic cells (acinic cells carcinoma [AcCC], 22 cases), adenoid cystic (adenoid cystic carcinoma [AdCC], 8 cases), (MASC, 6 cases), and adenocarcinoma (3 cases). Primary treatments were surgery (82 cases) and radiotherapy (20 cases; median dosage 64 gray). Cervical nodes therapy included WLND (≥2 levels, 29 cases), limited nodes resection (LNR; one level, 13 cases), and/or irradiation (4 cases; median 54 gray; range 52.0–63.0). At diagnosis, six patients had cervical node invasion (CNI) managed with LNR (four cases), WLND (two cases), and radiotherapy (three cases). After a median follow-up of 6 years (range 1–22), nine patients had tumor event: local (four cases), cervical relapse/progression (three cases) or combined (two cases). Of the nine with CNI, at diagnosis or relapse, four had MASC. Five-year event-free and overall survival (OS) rates were, respectively, 90.1% and 98.8%. Conclusions: CNI is rare in pediatric SGM but noted in 11% of cases, with higher incidence in MASC. Overall, outcome in SGM is good with a tailored locoregional multidisciplinary approach. Systematic lymph node dissection should be reconsidered. SUMMARY: This international multi-institutional study analyzed the clinical presentation and the cervical pattern of relapse of 82 pediatric patients with newly diagnosed salivary gland malignancies. Overall, nodal invasion was rare at diagnosis and only noted in 7%. In addition, 6% developed nodal relapse during follow-up. Incidence of nodal spread was frequent in mammary analogue secretory carcinoma (MASC). The overall outcome was promising with a tailored locoregional multidisciplinary approach. Systematic lymph node dissection should be reconsidered in pediatric salivary gland tumors.
KW - Salivary gland carcinoma
KW - children
KW - lymph node metastases
KW - lymph nodes dissection
KW - radiotherapy
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85216528017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216528017&partnerID=8YFLogxK
U2 - 10.1002/pbc.31581
DO - 10.1002/pbc.31581
M3 - Article
C2 - 39895422
AN - SCOPUS:85216528017
SN - 1545-5009
VL - 72
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 4
M1 - e31581
ER -